UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts

Haematologica (Roma), 2018-10, Vol.103 (10), p.1593-1603

2018

Volltextzugriff (PDF)

Switching From High‐Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report

HemaSphere, 2020-08, Vol.4 (4), p.e455-n/a

2020

Volltextzugriff (PDF)

Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network

Annals of hematology, 2020-10, Vol.99 (10), p.2303-2313

2020

Volltextzugriff (PDF)

Stable responses to danicopan as add-on to ravulizumab in two patients with paroxysmal nocturnal hemoglobinuria

Annals of hematology, 2024-08, Vol.103 (8), p.3235-3238

2024

Volltextzugriff (PDF)

Persistent parvovirus B19 infection in a heavily pretreated lymphoma patient receiving mosunetuzumab

Leukemia & lymphoma, 2024-09, p.1-3

2024

Volltextzugriff (PDF)

Diagnose und Therapie der erworbenen Aplastischen Anämie

Wiener klinische Wochenschrift Education, 2015-06, Vol.10 (1-2), p.15-28

Füreder, Wolfgang

2015

Volltextzugriff (PDF)

Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study

Blood, 2019-02, Vol.133 (6), p.530-539

2019

Volltextzugriff (PDF)

Resolution of extravascular hemolysis with oral iptacopan monotherapy in a patient with treatment experienced paroxysmal nocturnal hemoglobinuria (PNH)

Wiener Klinische Wochenschrift, 2024-08, Vol.136 (15-16), p.472-475

2024

Volltextzugriff (PDF)

The Mast Cell as Site of Tissue-Type Plasminogen Activator Expression and Fibrinolysis

The Journal of immunology (1950), 1999-01, Vol.162 (2), p.1032-1041

1999

Volltextzugriff (PDF)

Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML

Leukemia research, 2017-08, Vol.59, p.47-54

2017

Volltextzugriff (PDF)

Efficacy and Safety of Subcutaneous Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Prior Intravenous Eculizumab: 2-Year Follow-up

Blood, 2023-11, Vol.142 (Supplement 1), p.2713-2713

2023

Volltextzugriff (PDF)

Ravulizumab Provides Durable Control of Intravascular Hemolysis and Improves Survival in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Follow-up of Study 301 and Comparisons with Patients of the International PNH Registry

Blood, 2023-11, Vol.142 (Supplement 1), p.2714-2714

2023

Volltextzugriff (PDF)

The c-kit ligand stem cell factor and anti-igE promote expression of monocyte chemoattractant protein-1 in human lung mast cells

Blood, 1997-12, Vol.90 (11), p.4438-4449

1997

Volltextzugriff (PDF)

Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up

Advances in therapy, 2023-01, Vol.40 (1), p.211-232

2023

Volltextzugriff (PDF)

Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches

Leukemia & lymphoma, 2011-08, Vol.52 (8), p.1435-1445

2011

Volltextzugriff (PDF)

Major response of PNH to an AML chemotherapy protocol

Annals of hematology, 2018-08, Vol.97 (8), p.1487-1488

2018

Volltextzugriff (PDF)

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm

Wiener Klinische Wochenschrift, 2017-06, Vol.129 (11-12), p.404-410

2017

Volltextzugriff (PDF)

Evaluation of Angiogenesis and Vascular Endothelial Growth Factor Expression in the Bone Marrow of Patients with Aplastic Anemia

The American journal of pathology, 2006, Vol.168 (1), p.123-130

2006

Volltextzugriff (PDF)

Evaluation of treatment responses and colony-forming progenitor cells in 50 patients with aplastic anemia after immunosuppressive therapy or hematopoietic stem cell transplantation: a single-center experience

Wiener Klinische Wochenschrift, 2014-02, Vol.126 (3-4), p.119-125

2014

Volltextzugriff (PDF)

Desmoplakin and MPP1 as target antigens in patients with Paroxysmal nocturnal Hemoglobinuria

British journal of haematology, 2010-08, Vol.151 (3)

2010

Volltextzugriff (PDF)

Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuria

British journal of haematology, 2010-11, Vol.151 (3), p.273-280

2010

Volltextzugriff (PDF)

Switching From High-Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report

HemaSphere, 2020, Vol.4 (4), p.e455-e455

2020

Volltextzugriff (PDF)

Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells

The Journal of immunology (1950), 1995-09, Vol.155 (6), p.3152-3160

1995

Volltextzugriff (PDF)

The c-kit Ligand Stem Cell Factor and Anti-IgE Promote Expression of Monocyte Chemoattractant Protein-1 in Human Lung Mast Cells

Blood, 1997-12, Vol.90 (11), p.4438-4449

1997

Volltextzugriff (PDF)

Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics

Cancer management and research, 2011-05, Vol.3 (default), p.157-175

2011

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(20)
Hematology
(13)
Female
(11)
Male
(11)
Adult
(10)
Medicine
(10)
Medicine & Public Health
(10)
Middle Aged
(9)
Oncology
(8)
Aged
(6)
General & Internal Medicine
(6)
Medicine, General & Internal
(6)
Medicine/public Health
(6)
Biological And Medical Sciences
(5)
Endocrinology
(5)
Follow-Up Studies
(5)
Immunology
(5)
Immunosuppressive Agents - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts

Switching From High‐Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report

Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network

Stable responses to danicopan as add-on to ravulizumab in two patients with paroxysmal nocturnal hemoglobinuria

Persistent parvovirus B19 infection in a heavily pretreated lymphoma patient receiving mosunetuzumab

Diagnose und Therapie der erworbenen Aplastischen Anämie

Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study

Resolution of extravascular hemolysis with oral iptacopan monotherapy in a patient with treatment experienced paroxysmal nocturnal hemoglobinuria (PNH)

The Mast Cell as Site of Tissue-Type Plasminogen Activator Expression and Fibrinolysis

Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML

Efficacy and Safety of Subcutaneous Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Prior Intravenous Eculizumab: 2-Year Follow-up

Ravulizumab Provides Durable Control of Intravascular Hemolysis and Improves Survival in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Follow-up of Study 301 and Comparisons with Patients of the International PNH Registry

The c-kit ligand stem cell factor and anti-igE promote expression of monocyte chemoattractant protein-1 in human lung mast cells

Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up

Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches

Major response of PNH to an AML chemotherapy protocol

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm

Evaluation of Angiogenesis and Vascular Endothelial Growth Factor Expression in the Bone Marrow of Patients with Aplastic Anemia

Evaluation of treatment responses and colony-forming progenitor cells in 50 patients with aplastic anemia after immunosuppressive therapy or hematopoietic stem cell transplantation: a single-center experience

Desmoplakin and MPP1 as target antigens in patients with Paroxysmal nocturnal Hemoglobinuria

Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuria

Switching From High-Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report

Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells

The c-kit Ligand Stem Cell Factor and Anti-IgE Promote Expression of Monocyte Chemoattractant Protein-1 in Human Lung Mast Cells

Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics

Suchergebnisse filtern